课题基金 / 基金详情

项目摘要

项目成果

Kathryn L Sandberg的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recent studies indicate that T cells can modulate arterial pressure. We found that adoptive transfer of male but not female CD3+, CD4+ and CD8+ T cells can mediate Ang II-dependent hypertension in male Rag1 deficient mice. These observations indicate sex specific ations of T cells determine resistance and vulnerability in the regulation of hypertension by the immune system. In aim 1, we will determine if T cell-mediated susceptibility and resistance to hypertension induced by Ang II infusion in the male Rag1-/- host is due to gonad-dependent or gonad-independent effects of the sex chromosomes (XX vs XY) on the T cell donor and how these effects link to end organ damage and T cell responses. In aim 2, we will determine if sex-specific T cell subset responses to Ang II infusion in the male Rag1-/- host are due to sex differences in T cell angiotensin type 1 and type 2 receptors (AT1R and AT2R) and how these receptor- mediated T cell effects link to blood pressure, end organ damage and T cell function. Aim 3 will determine the role of pro- and anti-inflammatory cytokines in CD4+ and CD8+- mediated susceptibility and resistance to Ang II-induced hypertension and link these findings to end organ damage. Defining the mechanisms by which T cell sub- specification and T cell function are regulated by sex in a model of Ang II-dependent hypertension may provide an explanation for the delayed onset of hypertension in premenopausal women compared with age-matched men. Furthermore, discovering immune regulatory phenotypes associated with resistance and susceptibility to hypertension induced by Ang II could uncover T cell subset specific targets and strategies for treating hypertension in both sexes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting angiotensin II in cognitive impairment associated with ovarian hormone loss
  • 批准号:
    9751159
  • 项目类别:
  • 资助金额:
    $19.13万
  • 财政年份:
    2018
  • 负责人:
    Kathryn L Sandberg
  • 依托单位:
Immune Modulation of Hypertension
  • 批准号:
    9223751
  • 项目类别:
  • 资助金额:
    $48.06万
  • 财政年份:
    2015
  • 负责人:
    Kathryn L Sandberg
  • 依托单位:
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS)
  • 批准号:
    9084750
  • 项目类别:
  • 资助金额:
    $54.21万
  • 财政年份:
    2015
  • 负责人:
    Kathryn L Sandberg
  • 依托单位:
Aging impairments in angiotensin type 1 receptor actions
  • 批准号:
    8969870
  • 项目类别:
  • 资助金额:
    $23.33万
  • 财政年份:
    2015
  • 负责人:
    Kathryn L Sandberg
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: